{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:36:38Z","timestamp":1775554598813,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/leu.2014.335","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T07:38:48Z","timestamp":1417419528000},"page":"1060-1068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial"],"prefix":"10.1038","volume":"29","author":[{"given":"J","family":"Schetelig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sch\u00e4fer-Eckart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"H\u00e4nel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W E","family":"Aulitzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"R\u00f6sler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C D","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Serve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W E","family":"Berdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Oelschl\u00e4gel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Parmentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"R\u00f6llig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Illmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Study Alliance Leukemia (SAL)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"BFleu2014335_CR1","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075\u20134083.","journal-title":"Blood"},{"key":"BFleu2014335_CR2","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1182\/blood-2002-12-3714","volume":"102","author":"S Suciu","year":"2003","unstructured":"Suciu S, Mandelli F, de Witte T, Zittoun R, Gallo E, Labar B et al. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC\/GIMEMAAML-10 trial. Blood 2003; 102: 1232\u20131240.","journal-title":"Blood"},{"key":"BFleu2014335_CR3","first-page":"445","volume":"4","author":"AK Burnett","year":"2006","unstructured":"Burnett AK, Wheatley K, Goldstone AH, Stevens R, Hann I, Hills RK . Long-term results of the MRC AML10 trial. Clin Adv Hematol Oncol 2006; 4: 445\u2013451.","journal-title":"Clin Adv Hematol Oncol"},{"key":"BFleu2014335_CR4","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood-2006-06-025627","volume":"109","author":"JJ Cornelissen","year":"2007","unstructured":"Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM et al. Results of a HOVON\/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood 2007; 109: 3658\u20133666.","journal-title":"Blood"},{"key":"BFleu2014335_CR5","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2009.813","volume":"301","author":"J Koreth","year":"2009","unstructured":"Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009; 301: 2349\u20132361.","journal-title":"JAMA"},{"key":"BFleu2014335_CR6","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","volume":"26","author":"J Schetelig","year":"2008","unstructured":"Schetelig J, Bornhauser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol 2008; 26: 5183\u20135191.","journal-title":"J Clin Oncol"},{"key":"BFleu2014335_CR7","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1182\/blood-2010-04-278317","volume":"116","author":"V Gupta","year":"2010","unstructured":"Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood 2010; 116: 1839\u20131848.","journal-title":"Blood"},{"key":"BFleu2014335_CR8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.bbmt.2010.03.024","volume":"16","author":"A Woolfrey","year":"2010","unstructured":"Woolfrey A, Lee SJ, Gooley TA, Malkki M, Martin PJ, Pagel JM et al. HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category. Biol Blood Marrow Transplant 2010; 16: 1382\u20131387.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2014335_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bmt.2009.7","volume":"43","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275\u2013291.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014335_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bmt.1702819","volume":"27","author":"U Platzbecker","year":"2001","unstructured":"Platzbecker U, Thiede C, Freiberg-Richter J, Rollig C, Helwig A, Schakel U et al. Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia. Bone Marrow Transplant 2001; 27: 543\u2013546.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014335_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.leu.2404143","volume":"20","author":"U Platzbecker","year":"2006","unstructured":"Platzbecker U, Thiede C, Fussel M, Geissler G, Illmer T, Mohr B et al. Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia. Leukemia 2006; 20: 707\u2013714.","journal-title":"Leukemia"},{"key":"BFleu2014335_CR12","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1200\/JCO.2012.46.4743","volume":"31","author":"M Schaich","year":"2013","unstructured":"Schaich M, Parmentier S, Kramer M, Illmer T, Stolzel F, Rollig C et al. High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial. J Clin Oncol 2013; 31: 2094\u20132102.","journal-title":"J Clin Oncol"},{"key":"BFleu2014335_CR13","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V79.8.1924.1924","volume":"79","author":"PA Cassileth","year":"1992","unstructured":"Cassileth PA, Lynch E, Hines JD, Oken MM, Mazza JJ, Bennett JM et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992; 79: 1924\u20131930.","journal-title":"Blood"},{"key":"BFleu2014335_CR14","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1200\/JCO.2012.42.2907","volume":"30","author":"T Buchner","year":"2012","unstructured":"Buchner T, Schlenk RF, Schaich M, Dohner K, Krahl R, Krauter J et al. Acute myeloid leukemia (AML): different treatment strategies versus a common standard arm\u2013combined prospective analysis by the German AML Intergroup. J Clin Oncol 2012; 30: 3604\u20133610.","journal-title":"J Clin Oncol"},{"key":"BFleu2014335_CR15","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","volume":"99","author":"C Thiede","year":"2002","unstructured":"Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326\u20134335.","journal-title":"Blood"},{"key":"BFleu2014335_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1182\/blood-2002-02-0532","volume":"101","author":"W Kern","year":"2003","unstructured":"Kern W, Haferlach T, Schoch C, Loffler H, Gassmann W, Heinecke A et al. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood 2003; 101: 64\u201370.","journal-title":"Blood"},{"key":"BFleu2014335_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2307\/2529712","volume":"31","author":"SJ Pocock","year":"1975","unstructured":"Pocock SJ, Simon R . Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103\u2013115.","journal-title":"Biometrics"},{"key":"BFleu2014335_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S1470-2045(12)70349-2","volume":"13","author":"M Bornhauser","year":"2012","unstructured":"Bornhauser M, Kienast J, Trenschel R, Burchert A, Hegenbart U, Stadler M et al. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. Lancet Oncol 2012; 13: 1035\u20131044.","journal-title":"Lancet Oncol"},{"key":"BFleu2014335_CR19","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014335_CR20","first-page":"247","volume":"4","author":"K Atkinson","year":"1989","unstructured":"Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM . Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989; 4: 247\u2013254.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014335_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","volume":"64","author":"SJ Pocock","year":"1977","unstructured":"Pocock SJ . Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64: 191\u2013199.","journal-title":"Biometrika"},{"key":"BFleu2014335_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/sim.4780030106","volume":"3","author":"R Simon","year":"1984","unstructured":"Simon R, Makuch RW . A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med 1984; 3: 35\u201344.","journal-title":"Stat Med"},{"key":"BFleu2014335_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/bmt.2012.54","volume":"48","author":"RN Lown","year":"2013","unstructured":"Lown RN, Shaw BE . Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant 2013; 48: 210\u2013219.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014335_CR24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","volume":"31","author":"A Bashey","year":"2013","unstructured":"Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 2013; 31: 1310\u20131316.","journal-title":"J Clin Oncol"},{"key":"BFleu2014335_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","volume":"11","author":"M Eapen","year":"2010","unstructured":"Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653\u2013660.","journal-title":"Lancet Oncol"},{"key":"BFleu2014335_CR26","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bbmt.2014.05.015","volume":"20","author":"M Eapen","year":"2014","unstructured":"Eapen M, O'Donnell P, Brunstein CG, Wu J, Barowski K, Mendazibal A et al. Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. Biol Blood Marrow Transplant 2014; 20: 1485\u20131492.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2014335_CR27","first-page":"81","volume":"69","author":"N Mantel","year":"1974","unstructured":"Mantel N, Byar DP . Evaluation of response-time data involving transient states: an illustration using heart-transplant data. Biometrics 1974; 69: 81\u201386.","journal-title":"Biometrics"},{"key":"BFleu2014335_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation.V2012.1.1.3797038","volume":"2012","author":"AK Burnett","year":"2012","unstructured":"Burnett AK . Treatment of acute myeloid leukemia: are we making progress? Hematology Am Soc Hematol Educ Program 2012; 2012: 1\u20136.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFleu2014335_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/leu.2011.13","volume":"25","author":"C Craddock","year":"2011","unstructured":"Craddock C, Labopin M, Pillai S, Finke J, Bunjes D, Greinix H et al. Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia 2011; 25: 808\u2013813.","journal-title":"Leukemia"},{"key":"BFleu2014335_CR30","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","volume":"28","author":"M Duval","year":"2010","unstructured":"Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 2010; 28: 3730\u20133738.","journal-title":"J Clin Oncol"},{"key":"BFleu2014335_CR31","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","volume":"23","author":"C Schmid","year":"2005","unstructured":"Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ . Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005; 23: 5675\u20135687.","journal-title":"J Clin Oncol"},{"key":"BFleu2014335_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.bmt.1705965","volume":"41","author":"C Schmid","year":"2008","unstructured":"Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J et al. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. Bone Marrow Transplant 2008; 41: 721\u2013727.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014335_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbmt.2013.10.023","volume":"20","author":"ED Warlick","year":"2014","unstructured":"Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM et al. Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biol Blood Marrow Transplant 2014; 20: 202\u2013208.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014335","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:13:48Z","timestamp":1648743228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFleu2014335"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.335","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]},"assertion":[{"value":"23 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}